These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 765574

  • 1. [Antigenic analysis of the structural components of the surface of BCG cells].
    Shimono T, Kotani S, Kato K, Hirachi Y.
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):90. PubMed ID: 765574
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mycobacterium tuberculosis tuberculin devoid of BCG common antigens.
    Stavri D, Stavri H, Claiciu I, Niculescu D.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):399-401. PubMed ID: 6805158
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG).
    Minden P, Sharpton TR, McClatchy JK.
    J Immunol; 1976 May; 116(5):1407-14. PubMed ID: 58033
    [Abstract] [Full Text] [Related]

  • 6. Antigen study of Mycobacteria tuberculosis and BCG for detection of postvaccinal and infectious allergy.
    Mitinskaya LA.
    J Hyg Epidemiol Microbiol Immunol; 1975 May; 19(4):508-10. PubMed ID: 812912
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Immunologic methods of peroxidase detection in homogenates of bacilli of BCG substrains. II. Use of 2-dimensional immunoelectrophoresis for the immunologic demonstration of peroxidase].
    Lipińska R, Rzucidlo L.
    Gruzlica; 1975 Mar; 43(3):227-32. PubMed ID: 1090486
    [No Abstract] [Full Text] [Related]

  • 9. Antigenic composition of different BCG substrains studied by rocket-line immunoelectrophoresis.
    Stavri D, Niculescu D, Stavri H, Popa V.
    Arch Roum Pathol Exp Microbiol; 1981 Mar; 40(2):113-21. PubMed ID: 7030272
    [No Abstract] [Full Text] [Related]

  • 10. Antigenic cross-reactivity between Mycobacterium bovis (BCG) and Leishmania donovani.
    Smrkovski LL, Larson CL.
    Infect Immun; 1977 Nov; 18(2):561-2. PubMed ID: 336551
    [Abstract] [Full Text] [Related]

  • 11. [Model of allergy of the immediate type to BCG and analysis of allergic reactivity in BCG vaccination in experiments].
    Beklemishev ND, Sukhodoeva GS, Bul'vakhter IaL.
    Probl Tuberk; 1975 Nov; (12):53-8. PubMed ID: 768978
    [No Abstract] [Full Text] [Related]

  • 12. [Immunological properties of attenuated tuberculosis strain "BK-Kharkov". I. The comparative characteristics of the structural lipids and their relationship to the immunogenic properties of the "BK-Kharkov" and BCG strains].
    Dikiĭ IL, Cherkas GP, Kandyba SG, Bykova VK.
    Mikrobiol Zh; 1976 Nov; 38(3):325-30. PubMed ID: 820948
    [No Abstract] [Full Text] [Related]

  • 13. [Immunologic characterization of fractions of the BCG strain of M. bovis isolated by chromatofocusing].
    Nyabenda J, Pierre M, Keuterickx F, de Backer P.
    Dev Biol Stand; 1986 Nov; 58 ( Pt A)():43-52. PubMed ID: 3297875
    [No Abstract] [Full Text] [Related]

  • 14. Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG.
    Harboe M, Closs O, Svindahl K, Deverill J.
    Infect Immun; 1977 May; 16(2):662-72. PubMed ID: 324917
    [Abstract] [Full Text] [Related]

  • 15. Tumor regression mediated by Mycobacterium bovis (strain BCG).
    Zbar B.
    Natl Cancer Inst Monogr; 1972 Dec; 35():341-4. PubMed ID: 4572832
    [No Abstract] [Full Text] [Related]

  • 16. Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy.
    Melsom R, Naafs B, Harboe M, Closs O.
    Lepr Rev; 1978 Mar; 49(1):17-29. PubMed ID: 347205
    [No Abstract] [Full Text] [Related]

  • 17. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
    Mustafa AS.
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
    [Abstract] [Full Text] [Related]

  • 18. Production of monospecific antisera against antigenic componentsof Mycobacterium bovis (BCG).
    Harboe M, Closs O, Deverill J.
    Scand J Immunol; 1976 Jun; 5(6-7):861-6. PubMed ID: 790542
    [Abstract] [Full Text] [Related]

  • 19. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.
    Oettinger T, Jørgensen M, Ladefoged A, Hasløv K, Andersen P.
    Tuber Lung Dis; 1999 Jun; 79(4):243-50. PubMed ID: 10692993
    [Abstract] [Full Text] [Related]

  • 20. Catalase electrophoretic mobility of some BCG substrains.
    Stavri D, Stavri H.
    J Hyg Epidemiol Microbiol Immunol; 1975 Jun; 19(4):462-6. PubMed ID: 812907
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.